Urol. praxi, 2013; 14(3): 104-107

Epidemiology of bladder cancer

Mgr.Kateřina Vařechová, MUDr.Jana Povová, prof.MUDr.Vladimír Janout, CSc.
Ústav epidemiologie a ochrany veřejného zdraví, LF Ostravská univerziva v Ostravě

Bladder cancer is the most common cancer of the urinary system. In the ranking of all cancer it is the ninth most frequently diagnosed cancer

in the world. Incidence rates rises sharply with age but mortality remains relatively stable in recent years. The aim of this review is to give

a comprehensive view of bladder cancer. The first part of the review is devoted to the occurrence of bladder cancer in the Czech Republic and

in the world. The second part summarizes an overview about the potential risks and the protection factors for formation of bladder cancer.

Keywords: bladder cancer, epidemiology, risk factors, prevention

Published: July 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vařechová K, Povová J, Janout V. Epidemiology of bladder cancer. Urol. praxi. 2013;14(3):104-107.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Dušek L, Babjuk M, Mužík J, et al. Epidemiologie urologických nádorů v České republice - pilotní report shrnující nově validovaná data NOR za rok 2008 a predikce epidemiologické situace pro rok 2012 [online]. Masarykova univerzita, [2011], [cit. 2012-02-29]. Dostupný z WWW: http://www.uroweb.cz/index.php?pg=home&aid=56.
    2. Babjuk M, Petřík R, Jirsa M. Fluorescenční diagnostika nádorů močového měchýře. Praha: Triton, 2001: 126.
    3. Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, et al. Epidemiology of urinary bladder cancer: from tumor development to patient's death. J Urol 2007; 25(3): 285-295. Go to original source... Go to PubMed...
    4. Soukup V, Pešl M. Karcinom močového měchýře. Postgraduální medicína: Urologie 2011; 13(1).
    5. Minčík I. Diagnostika nádorov močového mechúra. Česká urologie 2009; 13(1): 43-60.
    6. Olfert SM, Felknor SA, Delclos GL. An Updated Review of the Literature: Risk Factors for Bladder Cancer with Focus on Occupational Exposures. Southern Medical Association 2006; 99(11): 1256-1263. Go to original source... Go to PubMed...
    7. Babjuk M, Matoušková M, Fínek J, Petruželka L. Konsenzuální doporučené postupy v uroonkologii. Praha: Galén 2009. ISBN 978-80-7262-639-7.
    8. Katolická J, Hrubá D. Faktory ovlivňující vznik karcinomu močového měchýře. Urol. praxi 2003; 4: 142-144.
    9. Mužík J, Dušek L, Babjuk M, et al. Uroweb - webový portál pro analýzu a vizualizaci epidemiologie, diagnostiky a léčby urologických malignit [online]. Masarykova univerzita, [2012], [cit. 2012-07-01]. Dostupný z WWW: http://www.uroweb.cz. Verze 1.6d.
    10. Dušek L, Mužík J, Kubásek M, et al. Epidemiologie zhoubných nádorů v České republice [online]. Masarykova univerzita, [2005], [cit. 2012-6-10]. Dostupný z WWW: http://www.svod.cz. Verze 7.0 [2007].
    11. Lotan Y, Amiel G, Boorjian SA, et al. Review article: Comprehensive handbook for developing a bladder cancer cystectomy database 2011: 1-15.
    12. Kiriluk KJ, et al. Bladder cancer risk from occupational and environmental exposures. Urologic Oncology: Seminars and Original Investigations 2012: 199-211. Go to original source... Go to PubMed...
    13. Silverman DT, Morrisson AS, Devesa SS. Cancer Epidemiology and Prevention. Second Edition. New York: Oxford University Press 1996. ISBN 0-19-505354-0.
    14. Brhel P, Fenclová Z. Profesionální nádorová onemocnění v České republice. Pracovní lékařství [online]. 2008; 60, (4): 162-167 [cit. 2012-04-18]. Dostupný na WWW: http://www.nemocizpovolani.cz/profesni_nadory.pdf.
    15. Colombel M, Soloway M, Akaza H, et al. Epidemiology, Staging, Grading, and RiskStratification of Bladder Cancer. European Urology Supplements. 2008; 7: 618-626. Go to original source...
    16. Karcinom močového měchýře. In: Masarykův onkologický ústav [online]. (C) 2009-2012, [cit. 2012-04-22]. Dostupné z WWW: http://www.mou.cz/file.html?id=85.
    17. Silberstein J, Parsons L. Lower Tract Urothelial Cancer: Evidence-based Principles of Bladder Cancer and Diet. UROLOGY 2010; 75(2): 340-346. Go to original source... Go to PubMed...
    18. Hall P. Radiation-associated urinary bladder cancer. Scandinavian Journal of Urology and Nephrology. 2008; 42(218): 85-88. Go to original source... Go to PubMed...
    19. Salem S, Mitchell RE, Smith JA. Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt. BJU INTERNATIONAL 2010; 107. Go to original source... Go to PubMed...
    20. Chronické infekce močových cest. Zdravotnické noviny: Příloha: Lékařské listy [online]. 2005; 26, [cit. 2012-05-02]. Dostupný z WWW: http://www.zdn.cz/clanek/priloha-lekarskelisty/chronicke-infekce-mocovych-cest-167554.
    21. Green J, Banks E, Berrington A, et al. N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction. British Journal of Cancer. 2000; 83(3): 412-417. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.